|
|
Volumn 4, Issue 1, 2002, Pages 47-55
|
|
An update on epidermal growth factor receptor inhibitors.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BISPECIFIC ANTIBODY;
EPIDERMAL GROWTH FACTOR RECEPTOR;
IMMUNOTOXIN;
LIGAND;
MONOCLONAL ANTIBODY;
PROTEIN TYROSINE KINASE;
VACCINE;
ANIMAL;
CELL CULTURE;
CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG EFFECT;
GENE THERAPY;
HUMAN;
METHODOLOGY;
NEOPLASM;
REVIEW;
SIGNAL TRANSDUCTION;
ANIMALS;
ANTIBODIES, BISPECIFIC;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
GENE THERAPY;
HUMANS;
IMMUNOTOXINS;
LIGANDS;
NEOPLASMS;
PROTEIN-TYROSINE KINASES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RESEARCH DESIGN;
SIGNAL TRANSDUCTION;
TUMOR CELLS, CULTURED;
VACCINES;
|
|
EID: 0036134210
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-002-0047-6 Document Type: Review |
|
Times cited : (28)
|
|
References (58)
|
